Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accordion, agent, analytical, Antylia, approach, bank, bioprocessing, Citibank, clarify, commerce, composed, conflict, continuum, Council, Cybersecurity, deficit, disease, excellence, explanatory, feature, fit, Ford, functional, geopolitical, greatest, Hach, home, hybrid, indirect, inflationary, injection, installment, lien, lifeline, LP, macroeconomic, manmade, merger, morale, Motor, nutrition, NYFRB, Orthopedic, overnight, penalty, prime, principle, prove, rationalization, rationalize, recession, repaid, resign, Russia, simple, slightly, strive, Sudhakar, sunset, thereto, thereunder, turn, Ukraine, unavailability, unregistered, Varshney, vital, WACC, wholly, wider
Removed:
accelerate, Aerospace, arrangement, assumption, Ball, Becton, block, breakthrough, comparing, Dave, David, Dickinson, doubtful, engineering, expand, forward, generate, infusion, instrumental, investing, nerve, obsolescence, organic, oversaw, peripheral, phase, post, rebranding, recently, recurring, retire, shortage, staggered, sustaining, swap, unsecured
Filing tables
Filing exhibits
- 10-K Annual report
- 10.19 Employment Offer Letter
- 10.20 Amendment to Employment Offer Letter
- 10.21 Amendment to Employment Offer Letter
- 21 Subsidiaries of the Corporation
- 23 Consent of Independent Registered Public Accounting Firm
- 24 Powers of Attorney
- 31 Section 302 CEO Certification
- 31 Section 302 CFO Certification
- 32 Section 906 CEO Certification
- 32 Section 906 CFO Certification
- Download Excel data file
- View Excel data file
Related press release
Associated AVNS transcripts
AVNS similar filings
Filing view
External links
Exhibit No. 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-199748, 333-233071 and 333-258016 on Form S-8 of our reports dated February 21, 2023, relating to the consolidated financial statements of Avanos Medical, Inc. and subsidiaries (the “Company”), and the effectiveness of the Company’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of Avanos Medical, Inc. for the year ended December 31, 2022.
/s/ DELOITTE & TOUCHE LLP | ||
Deloitte & Touche LLP | ||
Atlanta, Georgia | ||
February 21, 2023 |